| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―20 |
Characteristics of lung cancer patients with asymptomatic or undiagnosed SARS-CoV-2 infections |
Medha Somisetty, Philip C. Mack, Chih-Yuan Hsu, Yuanhui Huang, Jorge E. Gomez, Ananda M. Rodilla, Jazz Cagan, Sooyun C. Tavolacci, Juan Manuel Carreño, Rachel Brody, Amy C. Moore, Jennifer C. King, Nicholas C. Rohs, Christian Rolfo, Paul A. Bunn, John D. Minna, Sheena Bhalla, Florian Krammer, Adolfo García-Sastre, Jane C. Figueiredo, Elham Kazemian, Karen L. Reckamp, Akil A. Merchant, Maimoona Nadri, Rafi Ahmed, Suresh S. Ramalingam, Yu Shyr, Fred R. Hirsch, David E. Gerber |
| 2 |
[GO] |
2024―Apr―10 |
Brief Report: Impact of anti-cancer treatments on outcomes of COVID-19 in patients with thoracic cancers: a CCC19 registry analysis |
Amit A. Kulkarni, Cassandra Hennessy, Grace Wislon, Vidhyalakshmi Ramesh, Clara Hwang, Awosika Joy, Ziad Bakouny, Hina Khan, Diana Vilar-Compte, Rana McKay, Chinmay Jani, Lisa Weissmann, Elizabeth Griffiths, Gerald Batist, Nathaniel Bouganim, Blanche Mavromatis, Babar Bashir, Ryan H. Nguyen, Jonathan W. Riess, Matthew Puc, Anup Kasi, Stephanie Berg, Dan Ran Castillo, Brandon Hayes-Lattin, Wylie Hosmer, Daniel Flora, Sanjay Mishra, Benjamin French, Jeremy L. Warner, Gilberto Lopes, Solange Peters, Narjust Florez |
| 3 |
[GO] |
2023―Mar―21 |
Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 4 |
[GO] |
2023―Jan―25 |
Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients with Thoracic Malignancies |
Catherine B. Meador, Vivek Naranbhai, Grace Hambelton, Julia Rivera, Christopher S. Nabel, Rebecca Lewinsohn, Mustafa Sakhi, Alejandro B. Balazs, A. John Iafrate, Justin F. Gainor |
| 5 |
[GO] |
2022―May―05 |
Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic |
Nicholas R. Mayne, Simar S. Bajaj, Joseph Powell, Holly Elser, Barbara S. Civiello, Florian J. Fintelmann, Xiao Li, Chi-Fu Jeffrey Yang |
| 6 |
[GO] |
2021―Dec―24 |
Safety and efficacy of extended interval dosing for immune checkpoint inhibitors in non-small cell lung cancer during the COVID-19 pandemic |
L.B.M. Hijmering-Kappelle, T.J.N Hiltermann, F. Bensch |
| 7 |
[GO] |
2021―Aug―29 |
Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report |
Nathan Mynard, Ashish Saxena, Alexandra Mavracick, Jeffrey Port, Benjamin Lee, Sebron Harrison, Oliver Chow, Jonathan Villena-Vargas, Ronald Scheff, Giuseppe Giaccone, Nasser Altorki |
| 8 |
[GO] |
2021―Jun―12 |
The Role of Thoracic Surgeon in the Fight against COVID-19 Pandemic Frontline |
Yaodong Zhou |
| 9 |
[GO] |
2020―Aug―26 |
Tocilizumab for COVID-19 pneumonia in a non small cell lung cancer patient treated with chemo-immunotherapy |
M. Bonomi, M. Maltese, M. Brighenti, M. Muri, R. Passalacqua |
| 10 |
[GO] |
2020―Aug―25 |
Challenges in lung cancer patient management in times of COVID-19: an imaging perspective |
Luis Gorospe, Ana María Ayala-Carbonero, Patricia Paredes-Rodríguez, Gemma María Muñoz-Molina, Paola Arrieta, Rosa Mariela Mirambeaux-Villalona, María Carmen Vallejo-Ocaña, Amparo Benito-Berlinches, Yolanda Lage-Alfranca, Ana Gómez-Rueda |
| 11 |
[GO] |
2020―Jul―04 |
Considerations for the Surgical Management of Early Stage Lung Cancer during the COVID-19 Pandemic |
Robert E. Merritt, Peter J. Kneuertz |
| 12 |
[GO] |
2020―Jun―02 |
Differential diagnosis and clinical management of a case of COVID-19 in a stage III lung cancer patient treated with radio-chemotherapy and durvalumab. |
Andrea Emanuele Guerini, Paolo Borghetti, Andrea Riccardo Filippi, Marco Lorenzo Boné, Davide Tomasini, Diana Greco, Jessica Imbrescia, Giulia Volpi, Luca Triggiani, Andrea Borghesi, Roberto Maroldi, Nadia Pasinetti, Michela Buglione, Stefano Maria Magrini |
|
